Cargando…

SAT383 Case Study: Impact of Weight Reduction and Oral Contraceptive Pills on Hyperandrogenism

Disclosure: A. Syeda: None. T.L. Anderson: None. D. Millar: None. P. Madhavan: None. Introduction: Polycystic ovarian syndrome (PCOS) is a commonly encountered cause of hyperandrogenism which could interfere with fertility. Typical therapeutic options for hyperandrogenism including hormonal contrace...

Descripción completa

Detalles Bibliográficos
Autores principales:	Syeda, Asma, Anderson, Thea L, Millar, Danielle, Madhavan, Parvathy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555420/ http://dx.doi.org/10.1210/jendso/bvad114.1688

Ejemplares similares

SAT364 A Rare Cause of Hyperandrogenism in a Premenopausal Woman
por: Musa Penna, Laurianne El, et al.
Publicado: (2023)

SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
por: Chavez, Luis, et al.
Publicado: (2019)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

SAT368 Severe Hyperandrogenism in a Young Woman with Elevated BMI: A Case Study of The Role of Weight Loss in The Management of PCOS
por: Ortega, Susel Rodriguez, et al.
Publicado: (2023)

SAT360 Ovarian Vein Sampling in a Pre-menopausal Woman with Hyperandrogenism: Characterization of Hormonal Profiles
por: Hu, Tina Y, et al.
Publicado: (2023)

SAT369 Rare Cause of Hyperandrogenism and Elevated 17 OH Progesterone Levels - Ovarian Steroid Cell Tumor (NOS)
por: Shafi, Amtul, et al.
Publicado: (2023)

SAT-221 False-Positive Urinary Free Cortisol with Oral Contraceptive Use
por: Lavelle, Kristen, et al.
Publicado: (2019)

SAT-220 Oral Contraceptives and Their Effect on the Evaluation of Cushing's Syndrome: A Case Report
por: Ng, Zhi Guang, et al.
Publicado: (2019)

OR27-07 11-oxygenated C19 Steroids in Normal Weight, Overweight, and Hyperandrogenic Girls
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2020)

SAT-LB7 Acceptability of Oral 11β-Methyl-19-Nortestosterone Dodecylcarbonate (11β-MNTDC) as a Potential Hormonal Male Contraceptive Pill: Results From a Randomized, Placebo-Controlled Trial
por: Nguyen, Brian T, et al.
Publicado: (2020)

ODP416 Increased Ovarian Volume in Young Girls: A Marker of Impending Hyperandrogenism or Normal Variant?
por: Golob, Laura, et al.
Publicado: (2022)

Ovarian Hyperthecosis: Hyperandrogenism in a Post-Menopausal Woman
por: Fayad, Christine, et al.
Publicado: (2021)

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
por: Chen, Yen-Hao, et al.
Publicado: (2023)

THU646 Postmenopausal Hyperandrogenism Secondary To Ovarian Leydig Cell Tumor
por: Batch, Jennifer Tania, et al.
Publicado: (2023)

The Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss
por: Odhaib, Samih A, et al.
Publicado: (2021)

Post Menopausal Hyperandrogenism: A Case of a Steroid Cell Tumor of the Ovary
por: Hassan Nelson, Lauren Juliette, et al.
Publicado: (2021)

A Case of Hyperreactio Luteinalis Complicated With Biochemical Hyperandrogenism, Symptomatic Hyperthyroidism and Preeclampsia
por: Wong, K Y, et al.
Publicado: (2021)

OR04-04 Sexually Dimorphic Impact Of Gestational Hyperandrogenism On Offspring Growth Trajectory
por: Topaktas, Eylem, et al.
Publicado: (2023)

SAT-LB039 Development of an Animal Model of Long-acting, Reversible Contraception at Physiologic Equivalent Doses
por: Allaway, Heather, et al.
Publicado: (2019)

MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
por: folawewo, kehinde Matilda, et al.
Publicado: (2020)

A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills
por: Fattah, Abdul, et al.
Publicado: (2022)

THU643 Hyperandrogenism Caused By A Steroid Cell Tumor Of The Ovary In A Postmenopausal Woman
por: Mon Myint, Myat Su, et al.
Publicado: (2023)

PMON227 Rare ovarian luteinized fibrothecoma as cause of severe hyperandrogenism in a pre-menopausal woman.
por: Mikkilineni, Pushyami, et al.
Publicado: (2022)

FRI383 Androgen Receptor Signaling Regulates Follicular Growth And Steroidogenesis In The Ovary In Interaction With Gonadotropins During Mini-puberty In Mice
por: Devillers, Marie, et al.
Publicado: (2023)

Lack of Hirsutism in an XX Woman With History of Hyperandrogenism and Oligomenorrhea: Two Coexisting Disorders or Novel Syndrome of Androgen Insensitivity?
por: Ueda, Masako, et al.
Publicado: (2021)

LBMON232 A Hairy Situation: Ovarian Sex Cord Stromal Tumor As A Rare Cause Of Hyperandrogenism
por: Syed, Hasan, et al.
Publicado: (2022)

ODP420 Ovarian Venous Sampling and the Diagnostic Challenges Associated with Identifying the Source of Severe Hyperandrogenism in an Adolescent Female
por: Halpin, Kelsee, et al.
Publicado: (2022)

ODP411 Frequency of hyperandrogenism in Mexican adult women with type 1 diabetes mellitus: a pilot study.
por: García-Sãenz, Manuel, et al.
Publicado: (2022)

SAT-219 A Novel 1-Year Contraceptive Vaginal System Delivering Segesterone Acetate and Ethinyl Estradiol: Effects on Lipids and other Hepatic Proteins
por: Archer, David, et al.
Publicado: (2019)

SAT-013 Segesterone Acetate (SA) Serum Levels with a Statistical Model of Continued Use of the SA/Ethinyl Estradiol (EE) Contraceptive Vaginal System
por: Liu, James H, et al.
Publicado: (2020)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

MON-209 Systemic and Hypothalamic Hyperandrogenism Emerges Following Elimination of Ovarian and Extra-Ovarian Sources of Estradiol in Female Marmoset Monkeys
por: Kraynak, Marissa, et al.
Publicado: (2019)

Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis
por: Milali, Masabho P., et al.
Publicado: (2023)

OR31-05 Emergence of Ovarian Hyperandrogenism and Luteal Insufficiency Following ESR1 Knockdown in the Mediobasal Hypothalamus of Adult Female Rhesus Monkeys
por: Levine, Jon E, et al.
Publicado: (2020)

Skeletal Muscle Health in Polycystic Ovary Syndrome: Protective Effect of Hyperandrogenism or Detrimental Effect of Insulin Resistance? A Systematic Review and Meta-Analysis
por: Kazemi, Maryam, et al.
Publicado: (2021)

Need for Screening Triglyceride Levels in Women on Oral Contraceptives
por: Yau, Alice, et al.
Publicado: (2021)

OR31-01 A Randomized Controlled Trial of a Lifestyle Intervention with Longitudinal Follow up on Ovarian Dysmorphology, Hyperandrogenism, and Menstrual Irregularity in Women with Polycystic Ovary Syndrome
por: Kazemi, Maryam, et al.
Publicado: (2020)

SAT-196 Maternal immunity: Preimplantation Preparation
por: Elbert, Ashleigh, et al.
Publicado: (2019)

Agreement between self-reported and researcher-measured height, weight and blood pressure measurements for online prescription of the combined oral contraceptive pill: an observational study
por: McCulloch, Hannah, et al.
Publicado: (2022)

PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome
por: Azziz, Ricardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ftlv1g88hvqs4tim2lbk569h3